COVID antibody treatments show promise for preventing severe disease

In pandemic, potentially avoidable hospitalizations for non-COVID conditions fell more among whites

Novel coronavirus circulated undetected months before first COVID-19 cases in Wuhan, China

The Lancet: Seroprevalence study from Wuhan suggests 6.9% of population had COVID-19 antibodies by April 2020 -- including 40% with neutralizing antibodies that lasted for at least 9 months -- but 82% of cases were asymptomatic